SEC Stock Data Quick Answer ZEBRA TECHNOLOGIES CORP reported Long-Term Debt of $2.36 billion for fiscal year 2025. ZEBRA TECHNOLOGIES CORP Long-Term Debt — Annual History Fiscal Year Long-Term Debt YoY Change 2025 $2.36B +12.9% 2024 $2.09B +2.2% 2023 $2.05B +13.2% 2022 $1.81B +96.2% 2021 $922.00M +4.7% 2020 $881.00M -18.4% 2019 $1.08B -24.7% 2018 $1.43B -34.1% 2017 $2.18B … Read more
Quick Answer ZEBRA TECHNOLOGIES CORP reported Cash and Equivalents of $125.00 million for fiscal year 2025. ZEBRA TECHNOLOGIES CORP Cash and Equivalents — Annual History Fiscal Year Cash and Equivalents YoY Change 2025 $125.00M -86.1% 2024 $901.00M +557.7% 2023 $137.00M +30.5% 2022 $105.00M -68.4% 2021 $332.00M +97.6% 2020 $168.00M +460.0% 2019 $30.00M -31.8% 2018 $44.00M … Read more
Quick Answer ZEBRA TECHNOLOGIES CORP reported Total Assets of $8.50 billion for fiscal year 2025. ZEBRA TECHNOLOGIES CORP Total Assets — Annual History Fiscal Year Total Assets YoY Change 2025 $8.50B +6.7% 2024 $7.97B +9.1% 2023 $7.31B -3.0% 2022 $7.53B +21.1% 2021 $6.21B +15.6% 2020 $5.38B +14.1% 2019 $4.71B +8.6% 2018 $4.34B +1.5% 2017 $4.28B … Read more
Quick Answer ZEBRA TECHNOLOGIES CORP reported Diluted EPS of $8.18 per share for fiscal year 2025. ZEBRA TECHNOLOGIES CORP Diluted EPS — Annual History Fiscal Year Diluted EPS YoY Change 2025 $8.18 -19.6% 2024 $10.18 +78.0% 2023 $5.72 -35.0% 2022 $8.80 -43.3% 2021 $15.52 +66.0% 2020 $9.35 -6.2% 2019 $9.97 +28.5% 2018 $7.76 +2325.0% 2017 … Read more
Quick Answer ZEBRA TECHNOLOGIES CORP reported Net Income of $419.00 million for fiscal year 2025. ZEBRA TECHNOLOGIES CORP Net Income — Annual History Fiscal Year Net Income YoY Change 2025 $419.00M -20.6% 2024 $528.00M +78.4% 2023 $296.00M -36.1% 2022 $463.00M -44.7% 2021 $837.00M +66.1% 2020 $504.00M -7.4% 2019 $544.00M +29.2% 2018 $421.00M +2376.5% 2017 $17.00M … Read more
Quick Answer ZEBRA TECHNOLOGIES CORP reported Revenue (ASC 606) of $5.40 billion for fiscal year 2025. ZEBRA TECHNOLOGIES CORP Revenue (ASC 606) — Annual History Fiscal Year Revenue (ASC 606) YoY Change 2025 $5.40B +8.3% 2024 $4.98B +8.7% 2023 $4.58B -20.7% 2022 $5.78B +2.7% 2021 $5.63B +26.5% 2020 $4.45B -0.8% 2019 $4.49B +6.3% 2018 $4.22B … Read more
Quick Answer ZEBRA TECHNOLOGIES CORP reported Total Revenue of $5.40 billion for fiscal year 2025. ZEBRA TECHNOLOGIES CORP Total Revenue — Annual History Fiscal Year Total Revenue YoY Change 2025 $5.40B +8.3% 2024 $4.98B +8.7% 2023 $4.58B -20.7% 2022 $5.78B +2.7% 2021 $5.63B +26.5% 2020 $4.45B -0.8% 2019 $4.49B +6.3% 2018 $4.22B +13.3% 2017 $3.72B … Read more
Quick Answer ZEBRA TECHNOLOGIES CORP reported Total Revenue of $5.40 billion for fiscal year 2025. ZEBRA TECHNOLOGIES CORP — Key Financials by Year Metric 2025 2024 2023 2022 2021 2020 Total Revenue $5.40B+8.3% $4.98B+8.7% $4.58B-20.7% $5.78B+2.7% $5.63B+26.5% $4.45B-0.8% Revenue (ASC 606) $5.40B+8.3% $4.98B+8.7% $4.58B-20.7% $5.78B+2.7% $5.63B+26.5% $4.45B-0.8% Net Income $419.00M-20.6% $528.00M+78.4% $296.00M-36.1% $463.00M-44.7% $837.00M+66.1% $504.00M-7.4% … Read more
Quick Answer Zenas BioPharma, Inc. reported Shares Outstanding of 54.49 million shares for fiscal year 2025. Zenas BioPharma, Inc. Shares Outstanding — Annual History Fiscal Year Shares Outstanding YoY Change 2025 54.49M +30.4% 2024 41.79M +2550.4% 2023 1.58M — Quarterly Shares Outstanding Quarter Ending Shares Outstanding YoY QoQ September 30, 2025 42.21M +1.0% +0.3% June … Read more
Quick Answer Zenas BioPharma, Inc. reported Operating Income of -$383.06 million for fiscal year 2025. Zenas BioPharma, Inc. Operating Income — Annual History Fiscal Year Operating Income YoY Change 2025 -$383.06M -133.7% 2024 -$163.89M -341.2% 2023 -$37.15M — Quarterly Operating Income Quarter Ending Operating Income YoY QoQ September 30, 2025 -$52.58M -28.3% +4.7% June 30, … Read more